Literature DB >> 18831879

Adjuvant chemotherapy in oesophageal cancer: a meta-analysis and experience from the Shanghai Cancer Hospital.

J Zhang1, H-Q Chen, Y-W Zhang, J-Q Xiang.   

Abstract

Whether adjuvant chemotherapy increases survival of oesophageal cancer patients has been widely debated. The present study used meta-analysis software to combine data from six studies up to July 2007 that were found and selected as suitable, comprising a total of 1001 oesophageal cancer patients. The results indicated that adjuvant chemotherapy did not significantly improve outcome in oesophageal cancer patients. A trend towards improved outcome from adjuvant chemotherapy was found in lymph node-positive patients, but did not reach significance. In our own study including 270 oesophageal cancer patients, adjuvant chemotherapy did not improve overall patient survival, but did improve survival for patients with metastases in cervical and/or celiac lymph nodes (stage IVa). Although our study had the largest patient sample, more prospective clinical trials with large numbers of patients are necessary to confirm the value of adjuvant chemotherapy in stage IVa patients.

Entities:  

Mesh:

Year:  2008        PMID: 18831879     DOI: 10.1177/147323000803600502

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  9 in total

Review 1.  Perioperative management of esophageal cancer.

Authors:  Alicia Okines; Bhupinder Sharma; David Cunningham
Journal:  Nat Rev Clin Oncol       Date:  2010-03-09       Impact factor: 66.675

2.  The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.

Authors:  Yogesh Kumar Vashist; Asad Kutup; Safije Musici; Emre F Yekebas; Sormeh Mina; Guentac Uzunoglu; Oliver Zehler; Alexandra Koenig; Guelle Cataldegirmen; Maximillian Bockhorn; Katharina Effenberger; Viacheslav Kalinin; Klaus Pantel; Jakob R Izbicki
Journal:  Cell Oncol (Dordr)       Date:  2011-02-22       Impact factor: 6.730

3.  An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.

Authors:  Tarik Ghadban; Magdalena Schmidt-Yang; Magdalena Smif; Faik G Uzunoglu; Daniel R Perez; Tung Y Tsui; Alexander T El Gammal; Peter J Erbes; Veacheslav Zilbermints; Ulrich Wellner; Klaus Pantel; Jakob R Izbicki; Yogesh K Vashist
Journal:  J Hum Genet       Date:  2014-10-30       Impact factor: 3.172

4.  Multimodality management of esophageal cancer.

Authors:  Pallavi Purwar; Supriya Bambarkar; Sabita Jiwnani; George Karimundackal; Sarbani Ghosh Laskar; C S Pramesh
Journal:  Indian J Surg       Date:  2014-09-11       Impact factor: 0.656

5.  Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases.

Authors:  Yaping Xu; Qixun Chen; Xinmin Yu; Ximing Zhou; Xiao Zheng; Weimin Mao
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

6.  Multidrug resistance in primary tumors and metastases in patients with esophageal squamous cell carcinoma.

Authors:  Fang Qiang; Ren Guangguo; Han Yongtao; Dong Dandan; Yang Hong
Journal:  Pathol Oncol Res       Date:  2013-03-19       Impact factor: 3.201

7.  Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer.

Authors:  Yaping Xu; Jinshi Liu; Xianghui Du; Xiaojiang Sun; Yuanda Zheng; Jianxiang Chen; Bo Li; Wei Liu; Hao Jiang; Weimin Mao
Journal:  Radiat Oncol       Date:  2013-05-08       Impact factor: 3.481

8.  Efficacy of postoperative adjuvant chemotherapy for esophageal squamous cell carcinoma: A meta-analysis.

Authors:  Peiliang Zhao; Wanpu Yan; Hao Fu; Yao Lin; Ke-Neng Chen
Journal:  Thorac Cancer       Date:  2018-06-21       Impact factor: 3.500

9.  The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis.

Authors:  Xuyang Deng; Wenwu He; Yingchun Jiang; Sijie Deng; Tianqin Mao; Xuefeng Leng; Qiyu Luo; Kai Zheng; Yongtao Han
Journal:  Ann Transl Med       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.